Home Biotechnology Teva Pharmaceutical Industries Ltd.
T

Teva Pharmaceutical Industries Ltd.

Profile managed by Bizz Id
Israel 500+ employees 1901

Description

Biopharmaceutical company combining innovative medicines in neuroscience and immunology with a business in generics, complex generics, biosimilars and pharmacy brands. It has more than 30 biosimilars approved or in development, with biologics sites in Ulm (Germany), Philadelphia (USA) and Israel. Founded in Jerusalem in 1901; Ratiopharm is part of the group.

Products

24 products
Adalimumab

Brand: Simlandi (adalimumab-ryvk in the US). Biosimilar to Humira. US partner: Alvotech.

Aprobado FDA

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Adalimumab: see suppliers →

Aflibercept

Brand: Ahzantive. Biosimilar to Eylea. Partners: Klinge Biopharma and Formycon (EEA excl. Italy, UK, Switzerland, Israel).

Aprobado EMA

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Aflibercept: see suppliers →

Aflibercept (US filing)

Biosimilar to Eylea. Ophthalmology. Under regulatory review. US partner: Alvotech.

Solicitud presentada (EE. UU., agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Aflibercept: see suppliers →

Bevacizumab

Brand: Bevacizumab-Teva. Biosimilar to Avastin. Partner: mAbxience.

Aprobado Swissmedic

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Bevacizumab: see suppliers →

Denosumab (ref. Prolia)

US brand: Ponlimsi (denosumab-adet). Biosimilar to Prolia. Osteoporosis. Launched regionally in Europe.

Aprobado FDA; Lanzado en Europa (agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Denosumab: see suppliers →

Denosumab (ref. Xgeva)

US brand: Degevma (denosumab-adet). Biosimilar to Xgeva. Oncology. Launched regionally in Europe.

Aprobado FDA; Lanzado en Europa (agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Denosumab: see suppliers →

Duvakitug

Code TEV-'574. Ulcerative colitis and Crohn's disease. Phase 3. Partner: Sanofi.

Under development

Finished product (FDF)

Verified on 2026-10-21

Duvakitug: see suppliers →

Eculizumab

Brand: Epysqli (eculizumab-aagh in the US). Biosimilar to Soliris. US partner: Samsung Bioepis.

Aprobado FDA

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Eculizumab: see suppliers →

Filgrastim

Brands: Tevagrastim (EU, Israel, Brazil, Russia, Chile, Turkey, Paraguay), Inmunef (Mexico), Filgrastim Teva (South Africa), Granix (tbo-filgrastim, US). Biosimilar to Neupogen (biosimilar only per EMA; Granix is not considered a biosimilar in the US).

Aprobado EMA

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Filgrastim: see suppliers →

Fremanezumab

Brand: Ajovy (fremanezumab-vfrm in the US). Teva originator biologic. Injection.

Comercializado (agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Fremanezumab: see suppliers →

Golimumab (ref. Simponi Aria)

Biosimilar to Simponi Aria. Immunology. Under regulatory review. US partner: Alvotech.

Solicitud presentada (EE. UU., agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Golimumab: see suppliers →

Golimumab (ref. Simponi)

Biosimilar to Simponi. Immunology. Under regulatory review. US partner: Alvotech.

Solicitud presentada (EE. UU., agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Golimumab: see suppliers →

Ocrelizumab

Biosimilar to Ocrevus. Neurology. Pre-clinical. Partner: Polpharma.

Under development

Finished product (FDF)

Verified on 2026-10-21

Ocrelizumab: see suppliers →

Ocrelizumab + Hyaluronidase

Biosimilar to Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq). Neurology. Pre-clinical. Partner: Polpharma.

Under development

Finished product (FDF)

Verified on 2026-10-21

Ocrelizumab: see suppliers → · Hyaluronidase: see suppliers →

Omalizumab

Biosimilar to Xolair. Immunology, respiratory. Under regulatory review.

Solicitud presentada (agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Omalizumab: see suppliers →

Ranibizumab

Brands: Ranivisio (EU), Ranopto (Canada), Ongavia (UK). Biosimilar to Lucentis. Partner: Bioeq.

Comercializado (agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Ranibizumab: see suppliers →

Reslizumab

Brand: Cinqair. Teva originator biologic. Injection.

Comercializado (agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Reslizumab: see suppliers →

Rituximab

Brand: Truxima (rituximab-abbs in the US). Biosimilar to Rituxan. US and Canada partner: Celltrion.

Aprobado FDA; Aprobado Health Canada

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Rituximab: see suppliers →

TEV-'278 (anti-PD-1-IL-2)

Anti-PD1-IL2 (Attenukine). Oncology. Phase 1.

Under development

Finished product (FDF)

Verified on 2026-10-21

TEV-'408 (anti-IL-15)

Anti-IL-15. Celiac disease: Phase 2. Vitiligo: Phase 1.

Under development

Finished product (FDF)

Verified on 2026-10-21

Trastuzumab

Brand: Herzuma (trastuzumab-pkrb in the US). Biosimilar to Herceptin. US and Canada partner: Celltrion.

Aprobado Health Canada; Aprobado MHRA; Aprobado EMA

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Trastuzumab: see suppliers →

Ustekinumab

Brand: Selarsdi (ustekinumab-aekn in the US). Biosimilar to Stelara. US partner: Alvotech.

Aprobado FDA

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Ustekinumab: see suppliers →

Vedolizumab (IV)

Biosimilar to Entyvio (IV). Immunology. Under regulatory review. US partner: Alvotech.

Solicitud presentada (EE. UU., agencia no indicada)

Filing submitted

Finished product (FDF)

Verified on 2026-10-21

Vedolizumab: see suppliers →

Vedolizumab (SC)

Biosimilar to Entyvio SC. Immunology. Clinical stage. US partner: Alvotech.

Under development

Finished product (FDF)

Verified on 2026-10-21

Vedolizumab: see suppliers →

Contact company

Register for free to see this company’s contact details and get in touch.

Register - Free